BOURLA ALBERT
SEC CIK 1595703 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | COB, CEO, Dir | 429.2K | $1.00M | — | 15 | 2021-12-17 | 2026-08-12 |
Most active insiders at PFE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOURLA ALBERT | COB, CEO, Dir | $1.00M | — |
| 2 | BLAYLOCK RONALD E | Dir | $998.8K | — |
| 3 | Buckley Mortimer J | Dir | $960.4K | — |
| 4 | DAMICO JENNIFER B. | SVP, Ctrl | — | $134.7K |
| 5 | BOSHOFF CHRISTOFFEL | Pres, R, D | — | — |
| 6 | McDermott Michael | EVP | — | — |
| 7 | SAHNI PAYAL | EVP | — | — |
| 8 | LANKLER DOUGLAS M | EVP | — | — |
| 9 | Fonseca Lidia | EVP | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:04 | 2026-08-12 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | P - Purchase | $26.34 | +38.0K | 429.2K | +10% | +$1.00M | |
| DM | 2026-02-27 | 2026-02-25 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $26.92 | -475.5K | 388.7K | -55% | -$12.80M |
| D | 2026-02-27 | 2026-02-25 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $33.82 | +491.6K | 864.2K | +132% | +$16.63M |
| DM | 2025-03-03 | 2025-02-27 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $26.06 | -564.2K | 913.4K | -38% | -$14.70M |
| D | 2025-03-03 | 2025-02-27 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $31.31 | +582.8K | 931.7K | +167% | +$18.25M |
| D | 2025-02-25 | 2025-02-22 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $30.17 | +238.4K | 570.4K | +72% | +$7.19M |
| DM | 2025-02-25 | 2025-02-22 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $26.09 | -221.5K | 348.9K | -39% | -$5.78M |
| DM | 2024-02-27 | 2024-02-23 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $27.40 | -112.0K | 327.7K | -25% | -$3.07M |
| D | 2024-02-27 | 2024-02-23 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $27.34 | +127.7K | 439.7K | +41% | +$3.49M |
| 2023-02-28 | 2023-02-25 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $41.75 | -43.4K | 309.1K | -12% | -$1.81M | |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $42.38 | -62.0K | 352.5K | -15% | -$2.63M |
| DM | 2022-12-16 | 2022-12-16 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $27.25 | +222.3K | 411.9K | +117% | +$6.06M |
| 2022-03-01 | 2022-02-26 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $47.72 | -21.8K | 188.0K | -10% | -$1.04M | |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | F - Tax | $46.87 | -37.5K | 209.8K | -15% | -$1.76M |
| DM | 2021-12-21 | 2021-12-17 | PFE | Pfizer | BOURLA ALBERT | COB, CEO, Dir | M - OptEx | $26.73 | +123.1K | 203.5K | +153% | +$3.29M |
Purchase Sale Sale after option exercise All abbreviations